Filing Details
- Accession Number:
- 0001415889-21-001560
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-17 19:55:50
- Reporting Period:
- 2021-03-15
- Accepted Time:
- 2021-03-17 19:55:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1720568 | D Patrick Walsh | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-15 | 4,000 | $32.89 | 39,096 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The shares were acquired in multiple trades at prices ranging from $32.645 to $33.2699. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.